Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway.

Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway. Abstract Text:

Stefan Hofer,Christoph Eisenbach,Ivan K Lukic,Lutz Schneider,Konrad Bode,Martina Brueckmann,Sven Mautner,Moritz N Wente,Jens Encke,Jens Werner,Alexander H Dalpke,Wolfgang Stremmel,Peter P Nawroth,Eike Martin,Peter H Krammer,Angelika Bierhaus,Markus A Weigand,Stefan Hofer,Christoph Eisenbach,Ivan K Lukic,Lutz Schneider,Konrad Bode,Martina Brueckmann,Sven Mautner,Moritz N Wente,Jens Encke,Jens Werner,Alexander H Dalpke,Wolfgang Stremmel,Peter P Nawroth,Eike Martin,Peter H Krammer,Angelika Bierhaus,Markus A Weigand,

Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway. Publishing Authors By Initials

S Hofer,C Eisenbach,IK Lukic,L Schneider,K Bode,M Brueckmann,S Mautner,MN Wente,J Encke,J Werner,AH Dalpke,W Stremmel,PP Nawroth,E Martin,PH Krammer,A Bierhaus,MA Weigand,S Hofer,C Eisenbach,IK Lukic,L Schneider,K Bode,M Brueckmann,S Mautner,MN Wente,J Encke,J Werner,AH Dalpke,W Stremmel,PP Nawroth,E Martin,PH Krammer,A Bierhaus,MA Weigand,

For similar bacterial infections and mycoses: infection: sepsis research abstracts see: bacterial infections and mycoses: infection: sepsis research

PUBMED ID PMID:

MEDLINE DATE:

Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway. Journal Published:

PUBLICATION TYPE: Editorial

Journal: Critical care medicine

VOLUME: 36

Page Numbers: 622-3

Journal Abbreviation: Crit. Care Med.

ISSN: 1530-0293

DAY: 26

MONTH: Feb

YEAR: 2008

Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 355501

Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway. Keywords Mesh Terms:

KEYWORDS: Sepsis

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway. Information

Substance Name: Physostigmine

Registry Number: 57-47-6

Grant and Affiliation Information for Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Crit Care Med

REFSOURCE: Crit Care Med. 2008 Feb;36(2):404-8

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway Related Publications

• After-hours discharge from intensive care: impact on outcome.
• An intensivist-led tracheostomy review team is associated with shorter decannulation time and length of stay: a prospective cohort study.
• Cesariella, a new genus of Laboulbeniales.
• Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway.
• Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway.
• Colossal ionic conductivity at interfaces of epitaxial ZrO2:Y2O3/SrTiO3 heterostructures.
• Comments on 'the great legalization debate'.
• Contrasting effects of invasive plants in plant-pollinator networks.
• Cytoplasmic calcium mediates oxidative damage in an excitotoxic /energetic deficit synergic model in rats.
• Endoplasmic reticulum stress caused by overexpression of islet-specific glucose-6-phosphatase catalytic subunit-related protein in pancreatic Beta-cells.
• Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
• Group 13 organoderivatives supported on a metallic oxide model.
• High-level overproduction of Thermus enzymes in Streptomyces lividans.
• How Drosophila change their combs: the Hox gene Sex combs reduced and sex comb variation among Sophophora species.
• Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report.
• Initial models in conditionals: evidence from priming.
• Integrative hypothesis for Huntington's disease: a brief review of experimental evidence.
• Kynurenine pathway and disease: an overview.
• Quantification of electromyographic activity during REM sleep in multiple muscles in REM sleep behavior disorder.
• Remifentanil and the brain.
• Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke).
• Soret coefficients in some water-methanol, water-ethanol, and water-isopropanol systems.
• The Proline-Rich Sequence of CD3{epsilon} as an Amplifier of Low-Avidity TCR Signaling.
• [Carotid angiography; notes on the topographic and histologic diagnosis of cerebral tumors.]
• [In vitro effects of azaserine on normal and neoplastic tissue; polarographic behavior of azaserine.]
• [New derivatives of benzothiazole. I. Synthesis.]
• [New derivatives of benzothiazole. II. Antibacterial action and influence on respiratory systems of animal cells.]
• [Not Available.]
• [Systemic symptoms, cough and cavitated pulmonary nodule in an untreated HIV patient.]
• [The photodynamic properties of thiacoumarin compounds; lethal effects on paramecia and polarographic measurement of photo-oxidation in blood serum.]